Template:Uncomplicated Diverticulitis Antibiotics - Revision history

Danbot: Fix cite error: match AGA2021 ref text exactly with Diverticulitis page to resolve duplicate ref conflict

2026-03-21T01:02:44Z

Fix cite error: match AGA2021 ref text exactly with Diverticulitis page to resolve duplicate ref conflict

← Revisión anterior		Revisión del 01:02 21 mar 2026
Línea 1:		Línea 1:
	'''First, consider whether antibiotics are needed:'''		'''First, consider whether antibiotics are needed:'''
	*In immunocompetent patients with mild uncomplicated diverticulitis (no systemic signs, able to tolerate PO, reliable follow-up), a trial of '''supportive care alone''' (bowel rest, hydration, pain control) without antibiotics is reasonable<ref name="AGA2021">Peery AF, Shaukat A, Strate LL. AGA Clinical Practice Update on Medical Management of Colonic Diverticulitis: Expert Review. Gastroenterology. 2021;160(3):906-911.e1.</ref><ref name="ACP2022">Qaseem A, et al. Diagnosis and Management of Acute Left-Sided Colonic Diverticulitis: A Clinical Guideline From the American College of Physicians. Ann Intern Med. 2022;175(3):399-415.</ref>		*In immunocompetent patients with mild uncomplicated diverticulitis (no systemic signs, able to tolerate PO, reliable follow-up), a trial of '''supportive care alone''' (bowel rest, hydration, pain control) without antibiotics is reasonable<ref name="AGA2021">Peery AF, Shaukat A, Strate LL. AGA Clinical Practice Update on Medical Management of Colonic Diverticulitis: Expert Review. Gastroenterology. 2021;160(3):906-911.e1. doi:10.1053/j.gastro.2020.09.059</ref><ref name="ACP2022">Qaseem A, et al. Diagnosis and Management of Acute Left-Sided Colonic Diverticulitis: A Clinical Guideline From the American College of Physicians. Ann Intern Med. 2022;175(3):399-415.</ref>
	*Antibiotics ARE indicated if: immunocompromised, significant comorbidities/frailty, CRP >140 mg/L, WBC >15 × 10⁹/L, refractory symptoms, vomiting, or CT showing fluid collection or longer segment of inflammation<ref name="AGA2021"/>		*Antibiotics ARE indicated if: immunocompromised, significant comorbidities/frailty, CRP >140 mg/L, WBC >15 × 10⁹/L, refractory symptoms, vomiting, or CT showing fluid collection or longer segment of inflammation<ref name="AGA2021"/>

Danbot: Add disease=Diverticulitis parameter to AntibioticDose calls - fixes aggregation page display issue

2026-03-19T23:12:45Z

Add disease=Diverticulitis parameter to AntibioticDose calls - fixes aggregation page display issue

← Revisión anterior		Revisión del 23:12 19 mar 2026
Línea 6:		Línea 6:

	'''Preferred:'''		'''Preferred:'''
	*{{AntibioticDose\|drug=Amoxicillin/Clavulanate\|dose=875/125mg PO Q8hrs x 5 days\|context=Uncomplicated, Preferred}} (or Augmentin XR 2 tablets BID [each tablet 1gm [[Special:MyLanguage/amoxicillin\|amoxicillin]] 62.5mg clavulanate])<ref name="Bala2017">Balasubramanian I et al. Out-Patient Management of Mild or Uncomplicated Diverticulitis: A Systematic Review. Dig Surg. 2017;34(2):151-160.</ref><ref name="Gaber2021">Gaber CE, Kinlaw AC, Edwards JK, et al. Comparative Effectiveness and Harms of Antibiotics for Outpatient Diverticulitis: Two Nationwide Cohort Studies. Ann Intern Med. 2021;174(6):737-746. doi:10.7326/M20-6315</ref>		*{{AntibioticDose\|disease=Diverticulitis\|drug=Amoxicillin/Clavulanate\|dose=875/125mg PO Q8hrs x 5 days\|context=Uncomplicated, Preferred}} (or Augmentin XR 2 tablets BID [each tablet 1gm [[Special:MyLanguage/amoxicillin\|amoxicillin]] 62.5mg clavulanate])<ref name="Bala2017">Balasubramanian I et al. Out-Patient Management of Mild or Uncomplicated Diverticulitis: A Systematic Review. Dig Surg. 2017;34(2):151-160.</ref><ref name="Gaber2021">Gaber CE, Kinlaw AC, Edwards JK, et al. Comparative Effectiveness and Harms of Antibiotics for Outpatient Diverticulitis: Two Nationwide Cohort Studies. Ann Intern Med. 2021;174(6):737-746. doi:10.7326/M20-6315</ref>
	**Equally effective as fluoroquinolone + metronidazole with lower ''[[Special:MyLanguage/Clostridioides difficile\|C. difficile]]'' risk (especially in patients ≥65 years)<ref name="Gaber2021"/>		**Equally effective as fluoroquinolone + metronidazole with lower ''[[Special:MyLanguage/Clostridioides difficile\|C. difficile]]'' risk (especially in patients ≥65 years)<ref name="Gaber2021"/>
	**Avoids FDA black box fluoroquinolone risks (tendinopathy, neuropathy, aortic dissection, CNS effects)<ref name="FDA2016">FDA Drug Safety Communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects. July 26, 2016.</ref>		**Avoids FDA black box fluoroquinolone risks (tendinopathy, neuropathy, aortic dissection, CNS effects)<ref name="FDA2016">FDA Drug Safety Communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects. July 26, 2016.</ref>

	'''Alternatives (penicillin allergy or intolerance):'''		'''Alternatives (penicillin allergy or intolerance):'''
	*{{AntibioticDose\|drug=Trimethoprim/Sulfamethoxazole\|dose=one double-strength tablet BID\|context=Uncomplicated, PCN allergy}} PLUS {{AntibioticDose\|drug=Metronidazole\|dose=500mg PO Q8h x 5 days\|context=Uncomplicated, PCN allergy}}		*{{AntibioticDose\|disease=Diverticulitis\|drug=Trimethoprim/Sulfamethoxazole\|dose=one double-strength tablet BID\|context=Uncomplicated, PCN allergy}} PLUS {{AntibioticDose\|disease=Diverticulitis\|drug=Metronidazole\|dose=500mg PO Q8h x 5 days\|context=Uncomplicated, PCN allergy}}
	*{{AntibioticDose\|drug=Metronidazole\|dose=500mg PO Q8hrs\|context=Uncomplicated, Alternative}} PLUS {{AntibioticDose\|drug=Ciprofloxacin\|dose=500mg PO BID x 5 days\|context=Uncomplicated, Alternative}} (reserve for patients without non-fluoroquinolone options)<ref name="FDA2016"/>		*{{AntibioticDose\|disease=Diverticulitis\|drug=Metronidazole\|dose=500mg PO Q8hrs\|context=Uncomplicated, Alternative}} PLUS {{AntibioticDose\|disease=Diverticulitis\|drug=Ciprofloxacin\|dose=500mg PO BID x 5 days\|context=Uncomplicated, Alternative}} (reserve for patients without non-fluoroquinolone options)<ref name="FDA2016"/>
	*{{AntibioticDose\|drug=Moxifloxacin\|dose=400mg PO QDaily\|context=Uncomplicated, Alternative}} (same fluoroquinolone cautions apply)<ref name="Wilkins2013">Wilkins T et al. Diagnosis and Management of Acute Diverticulitis. Am Fam Physician. 2013 May 1;87(9):612-620.</ref>		*{{AntibioticDose\|disease=Diverticulitis\|drug=Moxifloxacin\|dose=400mg PO QDaily\|context=Uncomplicated, Alternative}} (same fluoroquinolone cautions apply)<ref name="Wilkins2013">Wilkins T et al. Diagnosis and Management of Acute Diverticulitis. Am Fam Physician. 2013 May 1;87(9):612-620.</ref>

Danbot: Convert to {{AntibioticDose}} for SMW antibiotic-disease linking

2026-03-19T22:51:25Z

Convert to {{AntibioticDose}} for SMW antibiotic-disease linking

← Revisión anterior		Revisión del 22:51 19 mar 2026
Línea 2:		Línea 2:
	*In immunocompetent patients with mild uncomplicated diverticulitis (no systemic signs, able to tolerate PO, reliable follow-up), a trial of '''supportive care alone''' (bowel rest, hydration, pain control) without antibiotics is reasonable<ref name="AGA2021">Peery AF, Shaukat A, Strate LL. AGA Clinical Practice Update on Medical Management of Colonic Diverticulitis: Expert Review. Gastroenterology. 2021;160(3):906-911.e1.</ref><ref name="ACP2022">Qaseem A, et al. Diagnosis and Management of Acute Left-Sided Colonic Diverticulitis: A Clinical Guideline From the American College of Physicians. Ann Intern Med. 2022;175(3):399-415.</ref>		*In immunocompetent patients with mild uncomplicated diverticulitis (no systemic signs, able to tolerate PO, reliable follow-up), a trial of '''supportive care alone''' (bowel rest, hydration, pain control) without antibiotics is reasonable<ref name="AGA2021">Peery AF, Shaukat A, Strate LL. AGA Clinical Practice Update on Medical Management of Colonic Diverticulitis: Expert Review. Gastroenterology. 2021;160(3):906-911.e1.</ref><ref name="ACP2022">Qaseem A, et al. Diagnosis and Management of Acute Left-Sided Colonic Diverticulitis: A Clinical Guideline From the American College of Physicians. Ann Intern Med. 2022;175(3):399-415.</ref>
	*Antibiotics ARE indicated if: immunocompromised, significant comorbidities/frailty, CRP >140 mg/L, WBC >15 × 10⁹/L, refractory symptoms, vomiting, or CT showing fluid collection or longer segment of inflammation<ref name="AGA2021"/>		*Antibiotics ARE indicated if: immunocompromised, significant comorbidities/frailty, CRP >140 mg/L, WBC >15 × 10⁹/L, refractory symptoms, vomiting, or CT showing fluid collection or longer segment of inflammation<ref name="AGA2021"/>

	'''If antibiotics are prescribed (4-7 day course preferred):'''<ref name="AGA2021"/>		'''If antibiotics are prescribed (4-7 day course preferred):'''<ref name="AGA2021"/>

	'''Preferred:'''		'''Preferred:'''
	*~~[[Special:MyLanguage/~~Amoxicillin/Clavulanate\|~~Amoxicillin/Clavulanate]]~~ 875/125mg PO Q8hrs x 5 days (or Augmentin XR 2 tablets BID [each tablet 1gm [[Special:MyLanguage/amoxicillin\|amoxicillin]] 62.5mg clavulanate])<ref name="Bala2017">Balasubramanian I et al. Out-Patient Management of Mild or Uncomplicated Diverticulitis: A Systematic Review. Dig Surg. 2017;34(2):151-160.</ref><ref name="Gaber2021">Gaber CE, Kinlaw AC, Edwards JK, et al. Comparative Effectiveness and Harms of Antibiotics for Outpatient Diverticulitis: Two Nationwide Cohort Studies. Ann Intern Med. 2021;174(6):737-746. doi:10.7326/M20-6315</ref>		*{{AntibioticDose\|drug=Amoxicillin/Clavulanate\|dose=875/125mg PO Q8hrs x 5 days\|context=Uncomplicated, Preferred}} (or Augmentin XR 2 tablets BID [each tablet 1gm [[Special:MyLanguage/amoxicillin\|amoxicillin]] 62.5mg clavulanate])<ref name="Bala2017">Balasubramanian I et al. Out-Patient Management of Mild or Uncomplicated Diverticulitis: A Systematic Review. Dig Surg. 2017;34(2):151-160.</ref><ref name="Gaber2021">Gaber CE, Kinlaw AC, Edwards JK, et al. Comparative Effectiveness and Harms of Antibiotics for Outpatient Diverticulitis: Two Nationwide Cohort Studies. Ann Intern Med. 2021;174(6):737-746. doi:10.7326/M20-6315</ref>
	**Equally effective as fluoroquinolone + metronidazole with lower ''[[Special:MyLanguage/Clostridioides difficile\|C. difficile]]'' risk (especially in patients ≥65 years)<ref name="Gaber2021"/>		**Equally effective as fluoroquinolone + metronidazole with lower ''[[Special:MyLanguage/Clostridioides difficile\|C. difficile]]'' risk (especially in patients ≥65 years)<ref name="Gaber2021"/>
	**Avoids FDA black box fluoroquinolone risks (tendinopathy, neuropathy, aortic dissection, CNS effects)<ref name="FDA2016">FDA Drug Safety Communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects. July 26, 2016.</ref>		**Avoids FDA black box fluoroquinolone risks (tendinopathy, neuropathy, aortic dissection, CNS effects)<ref name="FDA2016">FDA Drug Safety Communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects. July 26, 2016.</ref>

	'''Alternatives (penicillin allergy or intolerance):'''		'''Alternatives (penicillin allergy or intolerance):'''
	*~~[[Special:MyLanguage/~~Trimethoprim/Sulfamethoxazole\|~~Trimethoprim/Sulfamethoxazole]]~~ one double-strength tablet BID PLUS ~~[[Special:MyLanguage/~~Metronidazole\|~~Metronidazole]]~~ 500mg PO Q8h x 5 days		*{{AntibioticDose\|drug=Trimethoprim/Sulfamethoxazole\|dose=one double-strength tablet BID\|context=Uncomplicated, PCN allergy}} PLUS {{AntibioticDose\|drug=Metronidazole\|dose=500mg PO Q8h x 5 days\|context=Uncomplicated, PCN allergy}}
	*~~[[Special:MyLanguage/~~Metronidazole\|~~Metronidazole]]~~ 500mg PO Q8hrs PLUS ~~[[Special:MyLanguage/~~Ciprofloxacin\|~~Ciprofloxacin]]~~ 500mg PO BID x 5 days (reserve for patients without non-fluoroquinolone options)<ref name="FDA2016"/>		*{{AntibioticDose\|drug=Metronidazole\|dose=500mg PO Q8hrs\|context=Uncomplicated, Alternative}} PLUS {{AntibioticDose\|drug=Ciprofloxacin\|dose=500mg PO BID x 5 days\|context=Uncomplicated, Alternative}} (reserve for patients without non-fluoroquinolone options)<ref name="FDA2016"/>
	*~~[[Special:MyLanguage/~~Moxifloxacin\|~~Moxifloxacin]]~~ 400mg PO QDaily (same fluoroquinolone cautions apply)<ref name="Wilkins2013">Wilkins T et al. Diagnosis and Management of Acute Diverticulitis. Am Fam Physician. 2013 May 1;87(9):612-620.</ref>		*{{AntibioticDose\|drug=Moxifloxacin\|dose=400mg PO QDaily\|context=Uncomplicated, Alternative}} (same fluoroquinolone cautions apply)<ref name="Wilkins2013">Wilkins T et al. Diagnosis and Management of Acute Diverticulitis. Am Fam Physician. 2013 May 1;87(9):612-620.</ref>

Ostermayer at 16:33, 10 March 2026

2026-03-10T16:33:15Z

← Revisión anterior		Revisión del 16:33 10 mar 2026
Línea 1:		Línea 1:
	'''~~Options~~:'''		'''First, consider whether antibiotics are needed:'''
	*~~[[Metronidazole]] 500mg~~ PO ~~Q8hrs AND [[Ciprofloxacin]] 500mg PO BID x5days~~		*In immunocompetent patients with mild uncomplicated diverticulitis (no systemic signs, able to tolerate PO, reliable follow-up), a trial of '''supportive care alone''' (bowel rest, hydration, pain control) without antibiotics is reasonable<ref name="AGA2021">Peery AF, Shaukat A, Strate LL. AGA Clinical Practice Update on Medical Management of Colonic Diverticulitis: Expert Review. Gastroenterology. 2021;160(3):906-911.e1.</ref><ref name="ACP2022">Qaseem A, et al. Diagnosis and Management of Acute Left-Sided Colonic Diverticulitis: A Clinical Guideline From the American College of Physicians. Ann Intern Med. 2022;175(3):399-415.</ref>
	*[[Amoxicillin/Clavulanate]] 875/~~125~~ PO Q8hrs ~~x5days~~ (or [[Augmentin]] XR 2 tablets BID [each tablet 1gm [[amoxicillin]] 62.5mg clavulanate])<ref>Balasubramanian I et al. Out-Patient Management of Mild or Uncomplicated Diverticulitis: A Systematic Review. Dig Surg. 2017;34(2):151-160.</ref><ref>~~The STAND trial: Jaung R~~, ~~Nisbet S~~, ~~Gosselink MP~~, ~~Di Re A, Keane C, Lin A, Milne T, Su’a B, Rajaratnam S, Ctercteko G, Hsee L, Rowbotham D, Hill A, Bissett I~~. Antibiotics ~~Do Not Reduce Length of Hospital Stay~~ for ~~Uncomplicated~~ Diverticulitis ~~in a Pragmatic Double-Blind Randomized Trial~~. ~~Clin Gastroenterol Hepatol~~. ~~2020 Mar 30:S1542-3565~~(20)~~30426~~-2. doi: 10.~~1016~~/j.~~cgh~~.~~2020.03.049~~. ~~PMID: 32240832~~</ref>		*Antibiotics ARE indicated if: immunocompromised, significant comorbidities/frailty, CRP >140 mg/L, WBC >15 × 10⁹/L, refractory symptoms, vomiting, or CT showing fluid collection or longer segment of inflammation<ref name="AGA2021"/>
	*[[Trimethoprim/Sulfamethoxazole]], one double-strength tablet ~~bid, and~~ [[Metronidazole]] ~~500 mg~~ Q8h		'''If antibiotics are prescribed (4-7 day course preferred):'''<ref name="AGA2021"/>
	*[[Moxifloxacin]] 400mg PO QDaily<ref> Wilkins T et al. Diagnosis and Management of Acute Diverticulitis. Am Fam Physician. 2013 May 1;87(9):612-620.</ref>		'''Preferred:'''
			*[[Special:MyLanguage/Amoxicillin/Clavulanate\|Amoxicillin/Clavulanate]] 875/125mg PO Q8hrs x 5 days (or Augmentin XR 2 tablets BID [each tablet 1gm [[Special:MyLanguage/amoxicillin\|amoxicillin]] 62.5mg clavulanate])<ref name="Bala2017">Balasubramanian I et al. Out-Patient Management of Mild or Uncomplicated Diverticulitis: A Systematic Review. Dig Surg. 2017;34(2):151-160.</ref><ref name="Gaber2021">Gaber CE, Kinlaw AC, Edwards JK, et al. Comparative Effectiveness and Harms of Antibiotics for Outpatient Diverticulitis: Two Nationwide Cohort Studies. Ann Intern Med. 2021;174(6):737-746. doi:10.7326/M20-6315</ref>
			**Equally effective as fluoroquinolone + metronidazole with lower ''[[Special:MyLanguage/Clostridioides difficile\|C. difficile]]'' risk (especially in patients ≥65 years)<ref name="Gaber2021"/>
			**Avoids FDA black box fluoroquinolone risks (tendinopathy, neuropathy, aortic dissection, CNS effects)<ref name="FDA2016">FDA Drug Safety Communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects. July 26, 2016.</ref>
			'''Alternatives (penicillin allergy or intolerance):'''
			*[[Special:MyLanguage/Trimethoprim/Sulfamethoxazole\|Trimethoprim/Sulfamethoxazole]] one double-strength tablet BID PLUS [[Special:MyLanguage/Metronidazole\|Metronidazole]] 500mg PO Q8h x 5 days
			*[[Special:MyLanguage/Metronidazole\|Metronidazole]] 500mg PO Q8hrs PLUS [[Special:MyLanguage/Ciprofloxacin\|Ciprofloxacin]] 500mg PO BID x 5 days (reserve for patients without non-fluoroquinolone options)<ref name="FDA2016"/>
			*[[Special:MyLanguage/Moxifloxacin\|Moxifloxacin]] 400mg PO QDaily (same fluoroquinolone cautions apply)<ref name="Wilkins2013">Wilkins T et al. Diagnosis and Management of Acute Diverticulitis. Am Fam Physician. 2013 May 1;87(9):612-620.</ref>

Ostermayer at 01:57, 31 January 2022

2022-01-31T01:57:13Z

← Revisión anterior		Revisión del 01:57 31 ene 2022
Línea 1:		Línea 1:
	'''Options:'''		'''Options:'''
	*[[Metronidazole]] 500mg PO Q8hrs AND [[Ciprofloxacin]] 500mg PO BID ~~x10-14d~~		*[[Metronidazole]] 500mg PO Q8hrs AND [[Ciprofloxacin]] 500mg PO BID x5days
	*[[Amoxicillin/Clavulanate]] 875/125 PO Q8hrs ~~x10-14d~~ (or [[Augmentin]] XR 2 tablets BID [each tablet 1gm [[amoxicillin]] 62.5mg clavulanate])<ref>Balasubramanian I et al. Out-Patient Management of Mild or Uncomplicated Diverticulitis: A Systematic Review. Dig Surg. 2017;34(2):151-160.</ref>		*[[Amoxicillin/Clavulanate]] 875/125 PO Q8hrs x5days (or [[Augmentin]] XR 2 tablets BID [each tablet 1gm [[amoxicillin]] 62.5mg clavulanate])<ref>Balasubramanian I et al. Out-Patient Management of Mild or Uncomplicated Diverticulitis: A Systematic Review. Dig Surg. 2017;34(2):151-160.</ref><ref>The STAND trial: Jaung R, Nisbet S, Gosselink MP, Di Re A, Keane C, Lin A, Milne T, Su’a B, Rajaratnam S, Ctercteko G, Hsee L, Rowbotham D, Hill A, Bissett I. Antibiotics Do Not Reduce Length of Hospital Stay for Uncomplicated Diverticulitis in a Pragmatic Double-Blind Randomized Trial. Clin Gastroenterol Hepatol. 2020 Mar 30:S1542-3565(20)30426-2. doi: 10.1016/j.cgh.2020.03.049. PMID: 32240832</ref>
	*[[Trimethoprim/Sulfamethoxazole]], one double-strength tablet bid, and [[Metronidazole]] 500 mg Q8h		*[[Trimethoprim/Sulfamethoxazole]], one double-strength tablet bid, and [[Metronidazole]] 500 mg Q8h
	*[[Moxifloxacin]] 400mg PO QDaily<ref> Wilkins T et al. Diagnosis and Management of Acute Diverticulitis. Am Fam Physician. 2013 May 1;87(9):612-620.</ref>		*[[Moxifloxacin]] 400mg PO QDaily<ref> Wilkins T et al. Diagnosis and Management of Acute Diverticulitis. Am Fam Physician. 2013 May 1;87(9):612-620.</ref>

Zidovetz at 08:15, 5 April 2020

2020-04-05T08:15:02Z

← Revisión anterior		Revisión del 08:15 5 abr 2020
Línea 3:		Línea 3:
	*[[Amoxicillin/Clavulanate]] 875/125 PO Q8hrs x10-14d (or [[Augmentin]] XR 2 tablets BID [each tablet 1gm [[amoxicillin]] 62.5mg clavulanate])<ref>Balasubramanian I et al. Out-Patient Management of Mild or Uncomplicated Diverticulitis: A Systematic Review. Dig Surg. 2017;34(2):151-160.</ref>		*[[Amoxicillin/Clavulanate]] 875/125 PO Q8hrs x10-14d (or [[Augmentin]] XR 2 tablets BID [each tablet 1gm [[amoxicillin]] 62.5mg clavulanate])<ref>Balasubramanian I et al. Out-Patient Management of Mild or Uncomplicated Diverticulitis: A Systematic Review. Dig Surg. 2017;34(2):151-160.</ref>
	*[[Trimethoprim/Sulfamethoxazole]], one double-strength tablet bid, and [[Metronidazole]] 500 mg Q8h		*[[Trimethoprim/Sulfamethoxazole]], one double-strength tablet bid, and [[Metronidazole]] 500 mg Q8h
			*[[Moxifloxacin]] 400mg PO QDaily<ref> Wilkins T et al. Diagnosis and Management of Acute Diverticulitis. Am Fam Physician. 2013 May 1;87(9):612-620.</ref>

Ostermayer at 19:07, 12 March 2020

2020-03-12T19:07:35Z

← Revisión anterior		Revisión del 19:07 12 mar 2020
Línea 1:		Línea 1:
	'''Options:'''		'''Options:'''
	*[[Metronidazole]] 500mg PO Q8hrs AND [[Ciprofloxacin]] 500mg PO BID x10-14d		*[[Metronidazole]] 500mg PO Q8hrs AND [[Ciprofloxacin]] 500mg PO BID x10-14d
	*[[Amoxicillin/Clavulanate]] 875/125 PO ~~BID~~ x10-14d		*[[Amoxicillin/Clavulanate]] 875/125 PO Q8hrs x10-14d (or [[Augmentin]] XR 2 tablets BID [each tablet 1gm [[amoxicillin]] 62.5mg clavulanate])<ref>Balasubramanian I et al. Out-Patient Management of Mild or Uncomplicated Diverticulitis: A Systematic Review. Dig Surg. 2017;34(2):151-160.</ref>
	*[[Trimethoprim/Sulfamethoxazole]], one double-strength tablet bid, and [[Metronidazole]] 500 mg Q8h		*[[Trimethoprim/Sulfamethoxazole]], one double-strength tablet bid, and [[Metronidazole]] 500 mg Q8h

Bvoronin: Metronidazole from q6h to q8h dosing

2015-10-03T06:40:52Z

Metronidazole from q6h to q8h dosing

← Revisión anterior		Revisión del 06:40 3 oct 2015
Línea 2:		Línea 2:
	*[[Metronidazole]] 500mg PO Q8hrs AND [[Ciprofloxacin]] 500mg PO BID x10-14d		*[[Metronidazole]] 500mg PO Q8hrs AND [[Ciprofloxacin]] 500mg PO BID x10-14d
	*[[Amoxicillin/Clavulanate]] 875/125 PO BID x10-14d		*[[Amoxicillin/Clavulanate]] 875/125 PO BID x10-14d
	*[[Trimethoprim/Sulfamethoxazole]], one double-strength tablet bid, and [[Metronidazole]] 500 mg ~~Q6h~~		*[[Trimethoprim/Sulfamethoxazole]], one double-strength tablet bid, and [[Metronidazole]] 500 mg Q8h

Ostermayer at 21:08, 27 September 2015

2015-09-27T21:08:53Z

← Revisión anterior		Revisión del 21:08 27 sep 2015
Línea 1:		Línea 1:
	'''Options:'''		'''Options:'''
	*[[Metronidazole]] 500mg PO ~~Q8hrsAND~~ [[Ciprofloxacin]] 500mg PO BID x10-14d		*[[Metronidazole]] 500mg PO Q8hrs AND [[Ciprofloxacin]] 500mg PO BID x10-14d
	*[[Amoxicillin/Clavulanate]] 875/125 PO BID x10-14d		*[[Amoxicillin/Clavulanate]] 875/125 PO BID x10-14d
	*[[Trimethoprim/Sulfamethoxazole]], one double-strength tablet bid, and [[Metronidazole]] 500 mg Q6h		*[[Trimethoprim/Sulfamethoxazole]], one double-strength tablet bid, and [[Metronidazole]] 500 mg Q6h

Ostermayer at 21:08, 27 September 2015

2015-09-27T21:08:40Z

← Revisión anterior		Revisión del 21:08 27 sep 2015
Línea 1:		Línea 1:
	'''Options:'''		'''Options:'''
	*[[Metronidazole]] 500mg PO ~~Q6hrs AND~~ [[Ciprofloxacin]] 500mg PO BID x10-14d		*[[Metronidazole]] 500mg PO Q8hrsAND [[Ciprofloxacin]] 500mg PO BID x10-14d
	*[[Amoxicillin/Clavulanate]] 875/125 PO BID x10-14d		*[[Amoxicillin/Clavulanate]] 875/125 PO BID x10-14d
	*[[Trimethoprim/Sulfamethoxazole]], one double-strength tablet bid, and [[Metronidazole]] 500 mg Q6h		*[[Trimethoprim/Sulfamethoxazole]], one double-strength tablet bid, and [[Metronidazole]] 500 mg Q6h